How are JW and JZ modifiers handled?

The rules engine compares the documented dose with vial size, then applies the appropriate waste modifier before claim submission.

Can clinical-trial accounts stay separate?

Yes. Dedicated ledgers separate study-funded treatment from commercial and patient balances.

How are biosimilar substitutions billed correctly?

Reference products and their biosimilars are mapped to the correct HCPCS codes, so a substitution at the chair updates the charge instead of leaving a reference-product code on the claim.

Does the platform track regimen-level prior authorizations?

Authorizations are held against the regimen rather than a single visit, so remaining cycles, expiration dates, and unit counts stay visible to schedulers before the next treatment is booked.

How is buy-and-bill drug margin reported?

Acquisition cost, contracted reimbursement, and actual payment are compared by drug, regimen, and payer, so leadership can see which therapies are covering their cost and which are not.

How are chemotherapy denials worked?

Denials are grouped by reason, payer, and dollar value, then routed to the right queue with timely-filing deadlines surfaced first. US-based analysts in Cincinnati support appeals on high-value drug claims.

Does the platform handle 340B and split-billing scenarios?

340B and non-340B inventory can be tracked against separate ledgers with the appropriate modifiers applied, so covered-entity claims stay distinguishable from commercial purchases.

Oncology PM & RCM Software

The Leading Practice Management and RCM Billing Software for Oncology

Q: How long does an EMR integration take?

Most bi-directional integrations take 6–12 weeks, including workflow mapping, testing, and cutover support.

Connect treatment workflows, specialty billing rules, and reimbursement on one platform built for cancer care. Learn why Unlimited Systems is the trusted choice for Oncology practice management and RCM software.

Why oncology billing is different

Community oncology carries financial risk that general practice management software was never designed for. A single treatment day can combine a high-cost biologic, an administration sequence billed by the minute, a payer-specific step-therapy requirement, and discarded drug that has to be documented to be paid for.

When those details live in separate systems, the gaps show up as denied J-codes, unbilled wastage, expired authorizations, and drug margin no one can explain until the month closes. Oncology-specific rules and connected data are what keep those exceptions from becoming write-offs.

Cost Savings Calculator

★★★★★4.8/5

★★★★★5/5

6,500+ specialty providersSOC 2 certified

Caregiver holding a patient's hands in reassurance

Oncology RCM and practice management software dashboard

Trusted Payer & EHR Integration Partners

6,500+

providers nationwide

Over 50%

of US community oncology groups

$70B+

in claims processed annually

Designed Around How Your Oncology Practice ACTUALLY Works

Our connected workflows are built to make you and your work easier to do and increase your revenue.

Treatment-ready

Keep regimen authorization and coverage aligned before the chair is booked.

Claim-ready

Validate J-codes, dose details, and JW/JZ modifiers before submission.

Practice-ready

Give teams one view of denials, drug margin, and A/R priorities.

Specialty RCM intelligence

Oncology Revenue Cycle Challenges

Highest buy-and-bill complexity in any specialty.

22%

Est. denial rate

10/10

Prior-auth burden

Where revenue is at risk

Chemotherapy Drug Billing

HCPCS J-codes for high-cost agents; ASP+6% margin compression under Medicare; biosimilar substitution rules.

How the platform addresses this

J-code and NDC pairs are validated against the documented regimen before submission.
ASP-based fee schedules are modeled per payer, so margin compression is visible at order entry.
Biosimilar and reference-product substitutions update the charge automatically.

See it on your own claims

Buy-and-bill drug reference5 agents · codes, channel, prior-auth, and billing notes

Drug	Code	Route	Channel	Cost	PA	Billing notes
Keytruda (pembrolizumab)	J9271	IV	Part B	$180K/yr	Yes	Single-dose vial; JW required.
Opdivo (nivolumab)	J9299	IV	Part B	$150K/yr	Yes	Weight-based dosing complexity.
Herceptin (trastuzumab)	J9355	IV/SQ	Part B	$70K/yr	Yes	Biosimilar pressure from Kanjinti and Ogivri.
Avastin (bevacizumab)	J9035	IV	Part B	$55K/yr	Yes	Multi-use; partial vial tracking is critical.
Zometa (zoledronic acid)	J3489	IV	Part B	$2K/yr	Sometimes	Generic available; AWP vigilance needed.

Cabinet integration: Cabinet-to-EHR integration is critical because oncology practices may stock 30-60+ J-code drugs. Without ADC integration, partial-vial charge capture and wastage documentation gaps become a primary source of revenue leakage.

Your EHR and revenue cycle, connected

Move schedules, patient data, and charge details without duplicate entry.

Physician reviewing results at an office workstation

Bi-directional connection

Flatiron OncoEMR

Therapy documentation and financial workflow exchange.

What better oncology workflows look like

Oncology practices describe, in their own words, what changed after moving to Unlimited Systems.

Video testimonial

Hematology and Oncology Associates of Northeastern PA

Dunmore, PennsylvaniaIndependent Hematology & Oncology

“As I look back at the transition, the support and the collaboration with the folks at Unlimited really helped make us feel at ease. We had a partner that really wanted us to be successful.”

- Michelle Leandri, CEO, Hematology and Oncology Associates of Northeastern PA

Days in A/R shrank from 21 to 15, consistently.
Charges go out the next day.
Less manual work, more clean claims, and stronger cash flow.

Read the full case study

One platform for every oncology workflow

Eight connected capabilities, grouped around the way your practice works.

Front office

Keep registration and treatment calendars in sync.

Patient intake Scheduling

Before treatment

Verify coverage and catch charge risk early.

Financial clearance Charge validation

Revenue cycle

Post payments, route denials, and prioritize A/R.

Payment and denials A/R management

Practice intelligence

See margin, performance, and value-based results.

Analytics Value-based care

Financial performance dashboards on an office laptop

1.25%of drug spend typically left in waste

Challenges we solve for oncology

The work that generic platforms leave to your staff is the work oncology margin actually turns on.

Drug waste reconciled by hand after every infusion

Dose-to-vial rules apply JW/JZ before filing

Regimen authorizations tracked in portals and spreadsheets

Auth status stays tied to the regimen and the chair

Biosimilar swaps billed under the wrong reference code

Reference and biosimilar codes mapped at the charge

Drug margin only visible after the month closes

Acquisition-to-payment margin by regimen and payer

Built for oncology, not adapted to it

Compare the capabilities that matter most in buy-and-bill care.

Capability	Unlimited Financials	General platforms
JW/JZ waste automation	Built in	Often manual
Oncology dose validation	Preconfigured	Custom setup
Bi-directional EHR exchange	Supported	Varies
Oncology billing guidance	Included	General support

Need to compare a specific workflow?

Estimate your oncology RCM opportunity

Adjust three inputs to see an illustrative annual impact range.

Clinic profile inputs

Adjust the inputs to match your practice.

Number of oncology providers8

Monthly practice charges$350,000

Oncology biologics average high-value claims ($2,500+ per unit-dose infusion cycle).

Current denial rate12%

Biologic waste claim support (JW/JZ modifiers)Check to apply biological drug-waste modifier optimization to recapture discarded therapeutic drug claim fluids.

Estimated annual financial impact

Recapture up to $489,828

Claims recovery: $394,128
Effort recaptured: 960
A/R target: < 26 days

How these metrics are supported

Predefined rules screen out code modifier discrepancies at the point of service.
Real-time multi-state payer connectivity checks co-insurance margins before chemotherapy.
US-based Cincinnati billing analysts resolve complex appeals before timely filing limits lapse.

See your oncology ROI

Enter your work email to unlock your estimated annual financial impact.

See Your Results Immediately5/55/54.8/5

Still evaluating

Plan the decision before renewal pressure

A focused workflow review can show what to keep, what to fix, and whether a change is worth planning.

Request a demo

RCM software customer support: an Unlimited Systems support specialist with a headset at a computer

Start with a workflow review. We map J-codes, JW/JZ rules, authorizations, interfaces, and payer requirements before a transition is proposed.

Less billing work between treatment and payment

Specialty rules and connected data keep your team focused on the exceptions that need judgment.

Verify before treatment

Coverage and authorization stay tied to the regimen.

Validate specialty charges

Dose, vial, and modifier checks happen before filing.

Work the right accounts

Denials and A/R are ranked by value and filing risk.

Oncologist speaking with a patient during a cancer care visit

35%less manual workflow time

Sub-specialties

RCM software for Oncology sub-specialties

Each sub-specialty has its own coding, authorization, and payer rules. See how Unlimited Financials handles yours.

RCM software for Hematology: hematologist examining a blood smear under a microscope

Hematology RCM SoftwareBilling and practice management for hematology

RCM software for Radiation Oncology: radiation therapist positioning a patient at a linear accelerator

Radiation Oncology RCM SoftwareBilling and practice management for radiation oncology

RCM software for Surgical Oncology: surgical oncologist reviewing a treatment plan with a patient and her husband

Surgical Oncology RCM SoftwareBilling and practice management for surgical oncology

See the Medicare rules for your state

Preview the MAC jurisdiction and oncology checks mapped into the workflow.

Practice state

Medicare contractor

CGS Administrators

J15

Rule check: JW/JZ waste rules
Coverage policy: LCD L34028 · chemotherapy administration

Oncology billing questions

Most bi-directional integrations take 6–12 weeks, including workflow mapping, testing, and cutover support.

AI + Automation

AI & Automation for Oncology

Automatic JW/JZ drug-waste modifier capture at charge entry.
Chemo-regimen prior authorization checked before the visit, not after.
NCD/LCD medical-necessity rules validated automatically before submission.
Work by exception surfaces only the regimens with an actual risk.

Explore AI for Oncology

The Oncology suite

Every part of the oncology revenue cycle, in one system

Each module is configured for the codes, modifiers, and payer rules oncology teams work with — not adapted from generic billing software.

Oncology Patient Intake SoftwareCapture diagnosis, staging, and coverage detail at registration so the regimen starts financially clear.Oncology Scheduling SoftwareCoordinate chair time, nursing coverage, and drug availability across the treatment calendar.Oncology Financial Clearance SoftwareApply regimen-level prior authorization and step-therapy rules before the first cycle is booked.Oncology Charge Validation SoftwareValidate J-codes, NDC units, dose-to-vial math, and JW/JZ waste modifiers before claims leave.Oncology Payment Posting SoftwarePost and reconcile high-dollar drug remittances against contracted rates in one workflow.Oncology AR Management SoftwarePrioritize outstanding infusion and biologic claims by dollar value and timely-filing risk.Oncology Analytics SoftwareCompare drug margin, collection rates, and denial trends by regimen, provider, or payer.Oncology Value-Based Care SoftwareAggregate quality measure performance for bundled oncology payment and value-based contracts.

We Love Hearing From Our Users

Oncology and specialty practices, on what changed after moving to Unlimited Financials.

EXPLORE PRODUCTS GET A DEMO

★★★★★4.8/5

★★★★★5/5

“

The system continues to grow with features as it should, with how healthcare changes. So, if you are looking for a company that is innovative and truly cares, I would recommend Unlimited Financials.

Ernelita Dacumos

Billing Manager, SHOM

“

Unlimited Financials has been the easiest and best practice management system I have used. It is easy to navigate and do what I need to do.

Melissa Shook

Medical Biller, SHOM

“

We have been on Unlimited Financials for over three years and love it. Our claims are being processed faster and more efficiently, which means we are receiving payment more quickly.

Renee Bernacchi

Accounts Receivable Coordinator, COAS

“

Unlimited Financials has allowed us to extend our workforce in some areas due to the workflow efficiencies and given a better patient experience.

Mel Davies

CFO, Oregon Oncology Specialists

“

Knowledge of the patient's coverage has been a game changer. The ability to verify benefits before the patient comes in has saved us on time and denials, so there is no delay in treatment.

Alisha Haslem

Patient Advocate Manager, Utah Cancer Specialists

“

Using Unlimited Systems has allowed us to get a much better handle on our AR and claim management.

Erin Wilcher

Executive Director, Commonwealth Cancer Center

“